Literature DB >> 12837852

Binding of anandamide to bovine serum albumin.

Inge N Bojesen1, Harald S Hansen.   

Abstract

The endocannabinoid anandamide is of lipid nature and may thus bind to albumin in the vascular system, as do fatty acids. The knowledge of the free water-phase concentration of anandamide is essential for the investigations of its transfer from the binding protein to cellular membranes, because a water-phase shuttle of monomers mediates such transfers. We have used our method based upon the use of albumin-filled red cell ghosts as a dispersed biological "reference binder" to measure the water-phase concentrations of anandamide. These concentrations were measured in buffer (pH 7.3) in equilibrium with anandamide bound to BSA inside resealed human red cell membranes at low molar ratios below one. Data were obtained at 0 degrees C, 10 degrees C, 23 degrees C, and 37 degrees C. The equilibrium dissociation constant (Kd) increases with temperature from 6.87 +/- 0.53 nM at 0 degrees C to 54.92 +/- 1.91 nM at 37 degrees C. Regression analyses of the data suggest that BSA has one high-affinity binding site for anandamide at all four temperatures. The free energy of anandamide binding (DeltaG0) is calculated to -43.05 kJ mol-1 with a large enthalpy (DeltaH0) contribution of -42.09 kJ mol-1. Anandamide has vasodilator activity, and the binding to albumin may mediate its transport in aqueous compartments.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12837852     DOI: 10.1194/jlr.M300170-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  28 in total

1.  2-(3'-Indolyl)-N-arylthiazole-4-carboxamides: Synthesis and evaluation of antibacterial and anticancer activities.

Authors:  Mukund P Tantak; Jing Wang; Rajnish Prakash Singh; Anil Kumar; Kavita Shah; Dalip Kumar
Journal:  Bioorg Med Chem Lett       Date:  2015-08-06       Impact factor: 2.823

Review 2.  Endocannabinoid liberation from neurons in transsynaptic signaling.

Authors:  David M Lovinger
Journal:  J Mol Neurosci       Date:  2007-09       Impact factor: 3.444

3.  Opposing actions of endocannabinoids on cholangiocarcinoma growth is via the differential activation of Notch signaling.

Authors:  Gabriel Frampton; Monique Coufal; Huang Li; Jonathan Ramirez; Sharon DeMorrow
Journal:  Exp Cell Res       Date:  2010-03-25       Impact factor: 3.905

Review 4.  Circulating Endocannabinoids: From Whence Do They Come and Where are They Going?

Authors:  Cecilia J Hillard
Journal:  Neuropsychopharmacology       Date:  2017-06-27       Impact factor: 7.853

5.  Interaction of artemisinin and its derivatives with human serum albumin studied using spectroscopies and molecular modeling methods.

Authors:  Rongrong Chen; Hua Jiang; Hanlin Pu
Journal:  Mol Biol Rep       Date:  2013-05-06       Impact factor: 2.316

6.  Vascular effects of anandamide and N-acylvanillylamines in the human forearm and skin microcirculation.

Authors:  Pouya Movahed; Vladimir Evilevitch; Tomas L G Andersson; Bo A G Jönsson; Per Wollmer; Peter M Zygmunt; Edward D Högestätt
Journal:  Br J Pharmacol       Date:  2005-09       Impact factor: 8.739

Review 7.  2-Arachidonoylglycerol (2-AG) membrane transport: history and outlook.

Authors:  Anita Hermann; Martin Kaczocha; Dale G Deutsch
Journal:  AAPS J       Date:  2006       Impact factor: 4.009

Review 8.  Quantification of brain endocannabinoid levels: methods, interpretations and pitfalls.

Authors:  Matthew W Buczynski; Loren H Parsons
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

9.  The interaction of fatty acid amide hydrolase (FAAH) inhibitors with an anandamide carrier protein using (19)F-NMR.

Authors:  Jianqin Zhuang; De-Ping Yang; Spyros P Nikas; Jianhong Zhao; Jianxin Guo; Alexandros Makriyannis
Journal:  AAPS J       Date:  2013-01-24       Impact factor: 4.009

10.  The insertion and transport of anandamide in synthetic lipid membranes are both cholesterol-dependent.

Authors:  Eric Di Pasquale; Henri Chahinian; Patrick Sanchez; Jacques Fantini
Journal:  PLoS One       Date:  2009-03-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.